Literature DB >> 25174334

Restricted diversity of antigen binding residues of antibodies revealed by computational alanine scanning of 227 antibody-antigen complexes.

Gautier Robin1, Yoshiteru Sato2, Dominique Desplancq3, Natacha Rochel2, Etienne Weiss3, Pierre Martineau4.   

Abstract

Antibody molecules are able to recognize any antigen with high affinity and specificity. To get insight into the molecular diversity at the source of this functional diversity, we compiled and analyzed a non-redundant aligned collection of 227 structures of antibody-antigen complexes. Free energy of binding of all the residue side chains was quantified by computational alanine scanning, allowing the first large-scale quantitative description of antibody paratopes. This demonstrated that as few as 8 residues among 30 key positions are sufficient to explain 80% of the binding free energy in most complexes. At these positions, the residue distribution is not only different from that of other surface residues but also dependent on the role played by the side chain in the interaction, residues participating in the binding energy being mainly aromatic residues, and Gly or Ser otherwise. To question the generality of these binding characteristics, we isolated an antibody fragment by phage display using a biased synthetic repertoire with only two diversified complementarity-determining regions and solved its structure in complex with its antigen. Despite this restricted diversity, the structure demonstrated that all complementarity-determining regions were involved in the interaction with the antigen and that the rules derived from the natural antibody repertoire apply to this synthetic binder, thus demonstrating the robustness and universality of our results.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  X-ray crystal structure analysis; antibody library; binding free energy; protein–protein interaction

Mesh:

Substances:

Year:  2014        PMID: 25174334     DOI: 10.1016/j.jmb.2014.08.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  25 in total

1.  A General Synthetic Approach for Designing Epitope Targeted Macrocyclic Peptide Ligands.

Authors:  Samir Das; Arundhati Nag; JingXin Liang; David N Bunck; Aiko Umeda; Blake Farrow; Matthew B Coppock; Deborah A Sarkes; Amethist S Finch; Heather D Agnew; Suresh Pitram; Bert Lai; Mary Beth Yu; A Katrine Museth; Kaycie M Deyle; Bianca Lepe; Frances P Rodriguez-Rivera; Amy McCarthy; Belen Alvarez-Villalonga; Ann Chen; John Heath; Dimitra N Stratis-Cullum; James R Heath
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-17       Impact factor: 15.336

2.  Understanding differences between synthetic and natural antibodies can help improve antibody engineering.

Authors:  Anat Burkovitz; Yanay Ofran
Journal:  MAbs       Date:  2015-12-14       Impact factor: 5.857

3.  Reduction of Nonspecificity Motifs in Synthetic Antibody Libraries.

Authors:  Ryan L Kelly; Doris Le; Jessie Zhao; K Dane Wittrup
Journal:  J Mol Biol       Date:  2017-11-26       Impact factor: 5.469

4.  MoFvAb: Modeling the Fv region of antibodies.

Authors:  Alexander Bujotzek; Angelika Fuchs; Changtao Qu; Jörg Benz; Stefan Klostermann; Iris Antes; Guy Georges
Journal:  MAbs       Date:  2015       Impact factor: 5.857

5.  'Characterization of monoclonal antibodies generated to the 287-302 amino acid loop of the human epidermal growth factor receptor'.

Authors:  Eric Chun Hei Ho; Antonella Antignani; Robert Sarnovsky; David FitzGerald
Journal:  Antib Ther       Date:  2019-11-29

6.  The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats.

Authors:  Camila Cristina Pasquali; Zeyaul Islam; Douglas Adamoski; Igor Monteze Ferreira; Ricardo Diogo Righeto; Jefferson Bettini; Rodrigo Villares Portugal; Wyatt Wai-Yin Yue; Ana Gonzalez; Sandra Martha Gomes Dias; Andre Luis Berteli Ambrosio
Journal:  J Biol Chem       Date:  2017-05-19       Impact factor: 5.157

7.  Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.

Authors:  Yili Li; Brian G Pierce; Qian Wang; Zhen-Yong Keck; Thomas R Fuerst; Steven K H Foung; Roy A Mariuzza
Journal:  J Biol Chem       Date:  2015-03-03       Impact factor: 5.157

8.  Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera.

Authors:  Nileena Velappan; Devin Close; Li-Wei Hung; Leslie Naranjo; Colin Hemez; Natasha DeVore; Donna K McCullough; Antonietta M Lillo; Geoffrey S Waldo; Andrew R M Bradbury
Journal:  Protein Eng Des Sel       Date:  2021-02-15       Impact factor: 1.650

9.  Clonidine inhibits anti-non-Gal IgM xenoantibody elicited in multiple pig-to-primate models.

Authors:  John M Stewart; Alice F Tarantal; Wayne J Hawthorne; Evelyn J Salvaris; Philip J O'Connell; Mark B Nottle; Anthony J F d'Apice; Peter J Cowan; Mary Kearns-Jonker
Journal:  Xenotransplantation       Date:  2015-10-21       Impact factor: 3.907

Review 10.  Breaking the law: unconventional strategies for antibody diversification.

Authors:  Alexia Kanyavuz; Annaelle Marey-Jarossay; Sébastien Lacroix-Desmazes; Jordan D Dimitrov
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.